The trusted source for
healthcare information and
Dr. Rutrick (author) reports that her spouse owns a for-profit research facility and receives funding from Janssen, AbbVie, Indivior, Otsuka, Takeda, Sunovion, Acadia, Supernus, Novartis, Alkermes, Palatin, Roche, Sage, and Teva. All of the relationships of this individual have been mitigated. None of the other authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.